Literature DB >> 30055088

Area-Level Predictors of Medication Nonadherence Among US Medicaid Beneficiaries With Lupus: A Multilevel Study.

Candace H Feldman1, Karen H Costenbader1, Daniel H Solomon1, S V Subramanian2, Ichiro Kawachi2.   

Abstract

OBJECTIVE: Adherence to hydroxychloroquine (HCQ) treatment in patients with systemic lupus erythematous (SLE) is suboptimal. Although individual-level factors, including younger age and non-white race/ethnicity, have been implicated, contextual factors have not been explored. The aim of this study was to investigate the effect of contextual factors, including racial composition, socioeconomic status, and the concentration of health care resources, on adherence to HCQ among SLE patients enrolled in Medicaid.
METHODS: We identified SLE patients from 28 states in the US who enrolled in Medicaid (2000-2010) and in whom HCQ treatment was newly initiated (no use for ≥6 months). We required 12 months of continuous enrollment with complete drug dispensing data and measured adherence using the proportion of days covered (PDC). We identified individual-level variables from Medicaid, zip code-level, county-level and state-level sociodemographic variables from the American Community Survey, and health resources from Area Health Resources Files. We used 4-level hierarchical multivariable logistic regression models to examine the odds ratios (ORs) and 95% credible intervals (95% CrIs) of adherence (PDC ≥80%) versus nonadherence.
RESULTS: Among 10,268 patients with SLE in whom HCQ treatment was initiated, 15% were adherent to treatment. After we adjusted for individual-level characteristics, we observed lower odds of adherence among patients living in zip code areas with a higher percentage of black individuals (highest tertile OR 0.81 [95% CrI 0.69-0.96] versus lowest tertile). This association persisted after controlling for area-level educational attainment, percent below federal poverty level (FPL), urbanicity, and health care resources. We did not observe statistically significant associations with zip code-level percent Hispanic, percent white, education, or percent below FPL. The odds of adherence were higher in counties with more hospitals (OR 1.30 [95% CrI 1.07-1.58]).
CONCLUSION: Among Medicaid beneficiaries with SLE, we observed significant effects of racial composition and hospital concentration on HCQ adherence. Interventions that acknowledge and address contextual factors should be considered in order to reduce high rates of nonadherence in vulnerable populations.
© 2018, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30055088      PMCID: PMC6349545          DOI: 10.1002/acr.23721

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  38 in total

1.  Identification and validation of lupus nephritis cases using administrative data.

Authors:  L B Chibnik; E M Massarotti; K H Costenbader
Journal:  Lupus       Date:  2010-02-23       Impact factor: 2.911

2.  Medicare beneficiaries with depression: comparing diagnoses in claims data with the results of screening.

Authors:  Katia Noyes; Hangsheng Liu; Jeffrey M Lyness; Bruce Friedman
Journal:  Psychiatr Serv       Date:  2011-10       Impact factor: 3.084

3.  Medication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.

Authors:  Candace H Feldman; Jinoos Yazdany; Hongshu Guan; Daniel H Solomon; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-12       Impact factor: 4.794

4.  Patient characteristics associated with medication adherence.

Authors:  Sharon J Rolnick; Pamala A Pawloski; Brita D Hedblom; Stephen E Asche; Richard J Bruzek
Journal:  Clin Med Res       Date:  2013-04-11

5.  Morbidity of systemic lupus erythematosus: role of race and socioeconomic status.

Authors:  M Petri; S Perez-Gutthann; J C Longenecker; M Hochberg
Journal:  Am J Med       Date:  1991-10       Impact factor: 4.965

Review 6.  Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review.

Authors:  G Ruiz-Irastorza; M Ramos-Casals; P Brito-Zeron; M A Khamashta
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

7.  Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Araceli Garcia-Gonzalez; Marsha Richardson; Maria Garcia Popa-Lisseanu; Vanessa Cox; Michael A Kallen; Namieta Janssen; Bernard Ng; Donald M Marcus; John D Reveille; Maria E Suarez-Almazor
Journal:  Clin Rheumatol       Date:  2008-01-08       Impact factor: 2.980

Review 8.  Influence of Race, Ethnicity and Social Determinants of Health on Diabetes Outcomes.

Authors:  Rebekah J Walker; Joni Strom Williams; Leonard E Egede
Journal:  Am J Med Sci       Date:  2016-04       Impact factor: 2.378

9.  A study of racial/ethnic differences in treatment preferences among lupus patients.

Authors:  Ernest R Vina; Christopher M Masi; Stephanie L Green; Tammy O Utset
Journal:  Rheumatology (Oxford)       Date:  2012-05-30       Impact factor: 7.580

Review 10.  Social Determinants of Health, the Chronic Care Model, and Systemic Lupus Erythematosus.

Authors:  Edith M Williams; Kasim Ortiz; Teri Browne
Journal:  Int J Chronic Dis       Date:  2014-01-05
View more
  11 in total

1.  Multidisciplinary care in patients with systemic lupus erythematosus: a randomized controlled trial in China.

Authors:  Le Zhang; Shikai Geng; Liping Qian; Shuang Ye; Xiaodong Wang; Guohong Lu; Yang Ding; Ting Li
Journal:  Int J Clin Pharm       Date:  2019-06-25

2.  Predictors of Initial Hydroxychloroquine Receipt Among Medicaid Beneficiaries With Incident Systemic Lupus Erythematosus.

Authors:  Katherine P Pryor; Chang Xu; Jamie E Collins; Karen H Costenbader; Candace H Feldman
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-05-14       Impact factor: 5.178

3.  Lack of patient education is risk factor of disease flare in patients with systemic lupus erythematosus in China.

Authors:  Le Zhang; Wei Luan; Shikai Geng; Shuang Ye; Xiaodong Wang; Liping Qian; Yang Ding; Ting Li; Anli Jiang
Journal:  BMC Health Serv Res       Date:  2019-06-13       Impact factor: 2.655

Review 4.  Update on lupus epidemiology: advancing health disparities research through the study of minority populations.

Authors:  Cristina Drenkard; S Sam Lim
Journal:  Curr Opin Rheumatol       Date:  2019-11       Impact factor: 5.006

5.  Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA.

Authors:  Christopher F Bell; Julie Priest; Marni Stott-Miller; Hong Kan; Justyna Amelio; Xue Song; Brendan Limone; Virginia Noxon; Karen H Costenbader
Journal:  Lupus Sci Med       Date:  2020-03-26

6.  Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors.

Authors:  Laurent Arnaud; Maria G Tektonidou
Journal:  Rheumatology (Oxford)       Date:  2020-12-05       Impact factor: 7.580

Review 7.  Health disparities in systemic lupus erythematosus-a narrative review.

Authors:  Bilal Hasan; Alice Fike; Sarfaraz Hasni
Journal:  Clin Rheumatol       Date:  2022-07-31       Impact factor: 3.650

8.  Patient and healthcare team recommended medication adherence strategies for hydroxychloroquine: results of a qualitative study informing intervention development.

Authors:  Shivani Garg; Betty Chewning; David Gazeley; Shelby Gomez; Noah Kaitz; Amanda C Weber; Ann Rosenthal; Christie Bartels
Journal:  Lupus Sci Med       Date:  2022-08

Review 9.  Disparities in Lupus and Lupus Nephritis Care and Outcomes Among US Medicaid Beneficiaries.

Authors:  Katherine P Pryor; Medha Barbhaiya; Karen H Costenbader; Candace H Feldman
Journal:  Rheum Dis Clin North Am       Date:  2020-10-29       Impact factor: 2.670

10.  Medication decision-making and adherence in lupus: patient-physician discordance and the impact of previous 'adverse medical experiences'.

Authors:  Melanie Sloan; Elliott Lever; Caroline Gordon; Rupert Harwood; Sofia Georgopoulou; Felix Naughton; Chris Wincup; Stephen Sutton; David D'Cruz
Journal:  Rheumatology (Oxford)       Date:  2022-04-11       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.